Anavex Life Sciences Corp (AVXL)

[Steady_T]

I and others refer to Anavex growth from Rett. Missling has discussed the amount that might be charged for 2-73 to Rett patients insurance companies. That would bring in as much a billion Dollars annually. The amount of money funds a whole lot of new trials.

A partner would make money from selling 2-73 through its marketing network. Selling 2-73 would make a lot of money and the partner would pay Anavex a substantial amount of the sale revenues. Anavex would have the manufacturing and packaging costs.

Companies sell shares to raise money. You got that part right. What you left off is that properly used, that money increases the value of the shares more than the dilution decreases it. I trust MIssling because he has advanced 2-73 into multiple trials, so far with apparent success. He has done so a cost that most bio pharmas would consider impossibly low. The guy isn't perfect and so far his mistakes have not been sufficiently damaging to overcome the good things he has done.

And by the way your reply did not address the question of where all the expenses were going to come from that would require the massive share dilution you predict.